A new study from Israel is throwing more cold-water on the media’s narrative that COVID vaccines will be enough to stop the contagion’s highly infectious Omicron-variant, with data suggesting four injections of the medication is not enough to slow the new strain.
“Nearly a month after Sheba Medical Center launched a landmark study to test the efficacy of a fourth COVID shot, the hospital said Monday that this fourth booster was only partially effective in protecting against the Omicron strain,” reports the Times of Israel.
“The vaccine, which was very effective against the previous strains, is less effective against the Omicron strain,” said a lead researcher in the study.
“We see an increase in antibodies, higher than after the third dose,” added the academic. “However, we see many infected with Omicron who received the fourth dose. Granted, a bit less than in the control group, but still a lot of infections.”
“The bottom line is that the vaccine is excellent against the Alpha and Delta [variants], for Omicron it’s not good enough,” she said.
Read the full report at the Times of Israel.